DA Davidson Rates United Community Banks (UCB) buy
DA Davidson maintains its buy rating on UCB with a $40 price target, a 15.51% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
DA Davidson rated United Community Banks, Inc. ($UCB) "buy" with a $40 price target on June 15, 2026.
Since the rating, $UCB is down 0.2% after 1 week, up 7.7% after 1 month and up 2.7% to date (from the $33.20 close on Jun 15, 2026).
Key Points
- DA Davidson reiterated its buy rating on UCB, setting a price target of $40 on June 15, 2026.
- DA Davidson's $40 price target implies 15.51% upside from United Community Banks, Inc.'s ($UCB) current $34.63 share price.
- UCB shares are trading at $34.63, with institutional activity showing mixed changes among major funds.
- Recent insider buying at UCB includes purchases by several executives, while analysts maintain positive outlooks.
Get $UCB trade alerts by text
We text you when insiders, Congress or big funds trade $UCB. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated United Community Banks, Inc. alert may contain errors. Disclosures
DA Davidson has reiterated its buy rating on UCB, setting a new price target of $40. This reaffirmation came on June 15, 2026, as the stock traded at $34.63.
Other Institutional Activity in UCB
BlackRock, Inc. reduced its holdings in UCB by 90,024 shares, holding 17,861,636 shares valued at approximately $562.5 million. FMR LLC also trimmed its position by 156,450 shares, ending with 8,950,235 shares worth about $281.8 million. In contrast, Vanguard Portfolio Management LLC initiated a position with 8,044,992 shares valued at $253.3 million. Dimensional Fund Advisors LP increased its stake by 182,397 shares, bringing its total to 6,520,132 shares valued at $205.3 million. State Street Corp also boosted its holdings by 262,394 shares, totaling 6,232,961 shares worth nearly $197.8 million.
United Community Banks, Inc. Stock Down 0.2%
UCB shares are currently trading at $34.63. The stock has seen varied institutional activity, with some funds reducing and others increasing their positions.
$UCB price target
United Community Banks, Inc. daily closes and this analyst's $40 target. Not advice.
Insider Buying and Selling at United Community Banks, Inc.
Recent insider activity at UCB includes a sale by Alan Kumler, SVP and Chief Accounting Officer, who sold 113 shares at an average price of $32.06 on May 15, 2026. On May 13, 2026, several insiders, including David Wilkins, Sally Pope Davis, James Clements, Jennifer Mann, and Kenneth Daniels, each acquired 2,330 shares, although the price was not disclosed.
Analysts Set New Price Targets
On June 15, 2026, DA Davidson maintained its buy rating for UCB with a $40 price target. Previously, on April 28, 2026, Stephens & Co. also maintained a buy rating with the same target. Piper Sandler kept a hold rating with a $36 target on April 22, 2026. Keefe, Bruyette & Woods upgraded UCB to a buy with a $40 target on April 9, 2026.
About UCB
UCB is a global biopharmaceutical company that focuses on discovering and developing innovative medicines and solutions for people living with severe diseases in immunology and neurology. The company operates globally, with headquarters in Brussels, Belgium.
Bottom Line
DA Davidson's reiteration of a buy rating with a $40 target reflects continued confidence in UCB's prospects. Investors often track these analyst updates as they can provide insights into the company's potential. However, it's important to remember that these ratings are opinions and not guarantees of future performance.
Source: DA Davidson's rating change on $UCB (Jun 15, 2026). Written by software, not financial advice. How we make alerts